Fogacci, F.; Giovannini, M.; Grandi, E.; Imbalzano, E.; Degli Esposti, D.; Borghi, C.; Cicero, A.F.G.
Management of High-Risk Hypercholesterolemic Patients and PCSK9 Inhibitors Reimbursement Policies: Data from a Cohort of Italian Hypercholesterolemic Outpatients. J. Clin. Med. 2022, 11, 4701.
https://doi.org/10.3390/jcm11164701
AMA Style
Fogacci F, Giovannini M, Grandi E, Imbalzano E, Degli Esposti D, Borghi C, Cicero AFG.
Management of High-Risk Hypercholesterolemic Patients and PCSK9 Inhibitors Reimbursement Policies: Data from a Cohort of Italian Hypercholesterolemic Outpatients. Journal of Clinical Medicine. 2022; 11(16):4701.
https://doi.org/10.3390/jcm11164701
Chicago/Turabian Style
Fogacci, Federica, Marina Giovannini, Elisa Grandi, Egidio Imbalzano, Daniela Degli Esposti, Claudio Borghi, and Arrigo F. G. Cicero.
2022. "Management of High-Risk Hypercholesterolemic Patients and PCSK9 Inhibitors Reimbursement Policies: Data from a Cohort of Italian Hypercholesterolemic Outpatients" Journal of Clinical Medicine 11, no. 16: 4701.
https://doi.org/10.3390/jcm11164701
APA Style
Fogacci, F., Giovannini, M., Grandi, E., Imbalzano, E., Degli Esposti, D., Borghi, C., & Cicero, A. F. G.
(2022). Management of High-Risk Hypercholesterolemic Patients and PCSK9 Inhibitors Reimbursement Policies: Data from a Cohort of Italian Hypercholesterolemic Outpatients. Journal of Clinical Medicine, 11(16), 4701.
https://doi.org/10.3390/jcm11164701
